Detalles de la búsqueda
1.
PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.
Br J Surg;
108(3): 308-314, 2021 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33608712
2.
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
Ann Oncol;
30(10): 1541-1557, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31373601
3.
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Ann Oncol;
28(8): 1700-1712, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28838210
4.
Prognostic impact of breast cancer subtypes in elderly patients.
Breast Cancer Res Treat;
157(1): 91-9, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27107570
5.
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
Br J Cancer;
112(8): 1405-10, 2015 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25867274
6.
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Ann Oncol;
26(8): 1685-91, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25935792
7.
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Ann Oncol;
26(2): 313-20, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25403582
8.
The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer.
Br J Cancer;
111(5): 837-42, 2014 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25003667
9.
Lymphocyte infiltration predicts survival in chemotherapy-naive, triple-negative breast cancer and identifies patients with intrinsically good prognosis: have we been bringing owls to Athens?
Ann Oncol;
30(12): 1849-1850, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31626275
10.
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Ann Oncol;
30(7): 1181, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30624592
11.
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).
Ann Oncol;
25(2): 366-71, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24347519
12.
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Ann Oncol;
25(2): 339-45, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24347518
13.
Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T.
Eur Radiol;
24(4): 913-20, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24306425
14.
Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer.
Br J Cancer;
109(6): 1522-7, 2013 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-24002592
15.
Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series.
Br J Cancer;
108(11): 2259-63, 2013 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23722469
16.
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
Br J Cancer;
109(3): 589-96, 2013 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23868011
17.
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Br J Cancer;
108(7): 1408-14, 2013 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23511562
18.
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.
Br J Cancer;
109(12): 2959-64, 2013 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24157828
19.
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
Ann Oncol;
24(3): 640-7, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23035151
20.
Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.
Ann Oncol;
29(1): 281-282, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29045519